Bortezomib

被引：212

作者：

Paramore, A ^{[1
]}

Frantz, S ^{[1
]}

机构：

[1] Decis Resources Int, London WC1B 4HQ, England

来源：

NATURE REVIEWS DRUG DISCOVERY | 2003年 / 2卷 / 08期

关键词：

D O I：

10.1038/nrd1159

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

On 13 May 2003, Bortezomib (Velcade; Millenium) became the first proteasome inhibitor to be approved by the US FDA. Bortezomib was approved for multiple myeloma, a blood cancer that affects two to three people per 100,000, in record time — four months — on the basis of positive outcomes in early-phase trials.

引用

收藏

页码：611 / 612

页数：2

相关论文

共 11 条

[1] Proteasome inhibition in cancer: Development of PS-341 [J].

Adams, J .

SEMINARS IN ONCOLOGY, 2001, 28 (06) :613-619

[2] Potent and selective inhibitors of the proteasome: Dipeptidyl boronic acids [J].

Adams, J ;

Behnke, M ;

Chen, SW ;

Cruickshank, AA ;

Dick, LR ;

Grenier, L ;

Klunder, JM ;

Ma, YT ;

Plamondon, L ;

Stein, RL .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (04) :333-338

[3] Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].

Barnes, PJ ;

Larin, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071

[4] Structure and functions of the 20S and 26S proteasomes [J].

Coux, O ;

Tanaka, K ;

Goldberg, AL .

ANNUAL REVIEW OF BIOCHEMISTRY, 1996, 65 :801-847

[5]

Hideshima T, 2001, CANCER RES, V61, P3071

[6] How proteolysis drives the cell cycle [J].

King, RW ;

Deshaies, RJ ;

Peters, JM ;

Kirschner, MW .

SCIENCE, 1996, 274 (5293) :1652-1659

[7]

KISSLEV AF, 2001, CHEM BIOL, V121, P1

[8]

ORLOWSKI RZ, 2002, P AM SOC HEMATOL A, V388

[9] THE UBIQUITIN-PROTEASOME PATHWAY IS REQUIRED FOR PROCESSING THE NF-KAPPA-B1 PRECURSOR PROTEIN AND THE ACTIVATION OF NF-KAPPA-B [J].

PALOMBELLA, VJ ;

RANDO, OJ ;

GOLDBERG, AL ;

MANIATIS, T .

CELL, 1994, 78 (05) :773-785

[10] A phase 2 study of bortezomib in relapsed, refractory myeloma [J].

Richardson, PG ;

Barlogie, B ;

Berenson, J ;

Singhal, S ;

Jagannath, S ;

Irwin, D ;

Rajkumar, SV ;

Srkalovic, G ;

Alsina, M ;

Alexanian, R ;

Siegel, D ;

Orlowski, RZ ;

Kuter, D ;

Limentani, SA ;

Lee, S ;

Hideshima, T ;

Esseltine, DL ;

Kauffman, M ;

Adams, J ;

Schenkein, DP ;

Anderson, KC .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (26) :2609-2617